This was shared by "NYC Purple" on the other board
Post# of 72436
This preclinical research shows an experimental drug currently in phase I clinical trials can replace the immunity-protecting role lost when p53 fails.
http://www.news-medical.net/news/20151121/Cru...ancer.aspx
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)